このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Surgical Science Sweden マネジメント
マネジメント 基準チェック /44
Surgical Science Sweden'sの CEO はGisli Hennermarkで、 Sep2015年に任命され、 の在任期間は 1 年未満です。 の年間総報酬はSEK 5.83Mで、 73.7%給与と26.3%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.67%を直接所有しており、その価値はSEK 42.43M 。経営陣と取締役会の平均在任期間はそれぞれ3.7年と3.3年です。
主要情報
Gisli Hennermark
最高経営責任者
SEK 5.8m
報酬総額
| CEO給与比率 | 73.7% |
| CEO在任期間 | 9yrs |
| CEOの所有権 | 0.7% |
| 経営陣の平均在職期間 | 3.7yrs |
| 取締役会の平均在任期間 | 3.3yrs |
経営陣の近況
Recent updates
Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next
Aug 25
Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 21Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors
Apr 16Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump
Mar 17Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 24Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?
Nov 29Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?
Oct 07Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?
Aug 17With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case
Jun 20A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)
May 17Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate
Dec 27Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?
Dec 06Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Sep 08We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease
Aug 23Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless
May 26Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching
Apr 29An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued
Feb 20Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Jan 11Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?
Dec 15Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Sep 16Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Jul 05Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Jun 08Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Mar 23Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Mar 02Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?
Feb 09
Surgical Science Sweden AB (publ)'s (STO:SUS) Stock Is Going Strong: Have Financials A Role To Play?
Jan 01What Does Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Indicate?
Dec 14Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?
Nov 26CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | SEK 198m |
| Mar 31 2024 | n/a | n/a | SEK 208m |
| Dec 31 2023 | SEK 6m | SEK 4m | SEK 234m |
| Sep 30 2023 | n/a | n/a | SEK 253m |
| Jun 30 2023 | n/a | n/a | SEK 234m |
| Mar 31 2023 | n/a | n/a | SEK 221m |
| Dec 31 2022 | SEK 5m | SEK 4m | SEK 188m |
| Sep 30 2022 | n/a | n/a | SEK 138m |
| Jun 30 2022 | n/a | n/a | SEK 124m |
| Mar 31 2022 | n/a | n/a | SEK 101m |
| Dec 31 2021 | SEK 4m | SEK 3m | SEK 86m |
報酬と市場: Gisliの 総報酬 ($USD 571.06K ) は、 Swedish市場 ($USD 797.06K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Gisliの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Gisli Hennermark (52 yo)
9yrs
在職期間
SEK 5,826,000
報酬
Mr. Gisli Hennermark serves as Chief Executive Officer of Surgical Science Sweden AB (publ) since September 2015 and serves as it's Director since 2024. He serves as board member of Panasari AB and Espansa...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chief Executive Officer & Director | 9yrs | SEK 5.83m | 0.67% SEK 43.3m | |
| Co-Founder & CTO | 5.7yrs | データなし | 0.059% SEK 3.8m | |
| Chief Financial Officer | 6.7yrs | データなし | 0.047% SEK 3.0m | |
| Chief Operating Officer | 3.7yrs | データなし | 0.036% SEK 2.3m | |
| Head of Global Sales | 3.7yrs | データなし | データなし | |
| Executive Vice President of Products & Marketing | 2.8yrs | データなし | 0.036% SEK 2.3m | |
| Head of Development | 4.8yrs | データなし | データなし | |
| Chief Innovation Officer | 3.6yrs | データなし | データなし | |
| President of Research & Development | 2.7yrs | データなし | 0.042% SEK 2.7m | |
| Executive Vice President of International Sales & Educational Products | no data | データなし | 0.010% SEK 651.3k | |
| Executive Vice President of Industry & OEM | 2.3yrs | データなし | データなし |
3.7yrs
平均在職期間
55yo
平均年齢
経験豊富な経営陣: SUSの経営陣は 経験豊富 であると考えられます ( 3.4年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chief Executive Officer & Director | less than a year | SEK 5.83m | 0.67% SEK 43.3m | |
| Chairman of the Board | 19.7yrs | データなし | 11.74% SEK 758.0m | |
| Director | 19.7yrs | データなし | 13.99% SEK 903.0m | |
| Independent Director | 7.7yrs | データなし | 0.0020% SEK 126.5k | |
| Independent Director | 1.3yrs | データなし | 0.00069% SEK 44.5k | |
| Independent Director | 3.3yrs | データなし | 0.0026% SEK 164.6k | |
| Independent Director | 3.3yrs | データなし | 0.0020% SEK 126.5k |
3.3yrs
平均在職期間
52yo
平均年齢
経験豊富なボード: SUSの 取締役会 は 経験豊富 であると考えられます ( 5.3年の平均在任期間)。